Literature DB >> 17409627

Edaravone, a radical scavenger, inhibits mitochondrial permeability transition pore in rat brain.

Yuko Takayasu1, Junko Nakaki, Toshiyuki Kawasaki, Ken Koda, Yukio Ago, Akemichi Baba, Toshio Matsuda.   

Abstract

Edaravone, a radical scavenger, prevents ischemia/reperfusion injury in the brain, but the detailed mechanism is not known. This study examines the effect of edaravone on mitochondrial permeability transition pore (PTP) in rat brain. Edaravone at 10 - 100 microM inhibited Ca(2+)- and H(2)O(2)-induced swelling of mitochondria isolated from rat brain. Addition of Ca(2+) generated reactive oxygen species (ROS) in isolated mitochondria. Edaravone (10 - 100 microM) inhibited Ca(2+)-induced generation of ROS. These results suggest that edaravone inhibits opening of mitochondrial PTP in the brain, and they imply that inhibition of mitochondrial PTP may account for the neuroprotective effect of edaravone.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17409627     DOI: 10.1254/jphs.sc0070014

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  13 in total

1.  Protective effects of edaravone, a free radical scavenger, on lipopolysaccharide-induced acute kidney injury in a rat model of sepsis.

Authors:  Lin Liu; Yijin Song; Ming Zhao; Zhuwen Yi; Qiyi Zeng
Journal:  Int Urol Nephrol       Date:  2015-08-25       Impact factor: 2.370

2.  Does the concomitant intra-arterial injection of asialoerythropoietin and edaravone mitigate ischaemic mucosal damage after acute superior mesenteric artery thromboembolism in a rabbit autologous fibrin clot model?

Authors:  A Sonoda; N Nitta; A Seko; S Ohta; S Takemura; T Sugimoto; T Uzu; Y Yokomaku; M Takahashi; A Kashiwagi; K Murata
Journal:  Br J Radiol       Date:  2009-06-22       Impact factor: 3.039

3.  Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neurons.

Authors:  Wen Ji Yuan; Takao Yasuhara; Tetsuro Shingo; Kenichiro Muraoka; Takashi Agari; Masahiro Kameda; Takashi Uozumi; Naoki Tajiri; Takamasa Morimoto; Meng Jing; Tanefumi Baba; Feifei Wang; Hanbai Leung; Toshihiro Matsui; Yasuyuki Miyoshi; Isao Date
Journal:  BMC Neurosci       Date:  2008-08-01       Impact factor: 3.288

Review 4.  The efficacy of edaravone (radicut), a free radical scavenger, for cardiovascular disease.

Authors:  Kiyoshi Kikuchi; Salunya Tancharoen; Nobuyuki Takeshige; Munetake Yoshitomi; Motohiro Morioka; Yoshinaka Murai; Eiichiro Tanaka
Journal:  Int J Mol Sci       Date:  2013-07-04       Impact factor: 5.923

5.  Edaravone decreases paraquat toxicity in a549 cells and lung isolated mitochondria.

Authors:  Mohammad Shokrzadeh; Fatemeh Shaki; Ebrahim Mohammadi; Neda Rezagholizadeh; Fatemeh Ebrahimi
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

Review 6.  Edaravone and cyclosporine A as neuroprotective agents for acute ischemic stroke.

Authors:  Shohei Matsumoto; Michihiro Murozono; Masahiro Kanazawa; Takeshi Nara; Takuro Ozawa; Yasuo Watanabe
Journal:  Acute Med Surg       Date:  2018-05-17

Review 7.  Oxidative Stress in Amyotrophic Lateral Sclerosis: Pathophysiology and Opportunities for Pharmacological Intervention.

Authors:  Teresa Cunha-Oliveira; Liliana Montezinho; Catarina Mendes; Omidreza Firuzi; Luciano Saso; Paulo J Oliveira; Filomena S G Silva
Journal:  Oxid Med Cell Longev       Date:  2020-11-15       Impact factor: 6.543

Review 8.  Targeting the Mitochondrial Permeability Transition Pore to Prevent Age-Associated Cell Damage and Neurodegeneration.

Authors:  Andrew C Kent; Khairat Bahgat Youssef El Baradie; Mark W Hamrick
Journal:  Oxid Med Cell Longev       Date:  2021-01-28       Impact factor: 6.543

9.  Grifolin Attenuates White Matter Lesion in Oxygen/Glucose Deprivation.

Authors:  Ying Yanqin; Tang Jing; Chen Wei; Li Nan
Journal:  Transl Neurosci       Date:  2017-10-15       Impact factor: 1.757

10.  Efficacy of a mitochondrion-targeting agent for reducing the level of urinary protein in rats with puromycin aminonucleoside-induced minimal-change nephrotic syndrome.

Authors:  Yuko Fujii; Hideki Matsumura; Satoshi Yamazaki; Akihiko Shirasu; Hyogo Nakakura; Tohru Ogihara; Akira Ashida
Journal:  PLoS One       Date:  2020-01-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.